Xiaoli Wei

5.4k total citations · 1 hit paper
88 papers, 4.3k citations indexed

About

Xiaoli Wei is a scholar working on Molecular Biology, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Xiaoli Wei has authored 88 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 28 papers in Biomaterials and 24 papers in Biomedical Engineering. Recurrent topics in Xiaoli Wei's work include Nanoparticle-Based Drug Delivery (26 papers), RNA Interference and Gene Delivery (17 papers) and Nanoplatforms for cancer theranostics (14 papers). Xiaoli Wei is often cited by papers focused on Nanoparticle-Based Drug Delivery (26 papers), RNA Interference and Gene Delivery (17 papers) and Nanoplatforms for cancer theranostics (14 papers). Xiaoli Wei collaborates with scholars based in China, United States and South Korea. Xiaoli Wei's co-authors include Weiyue Lu, Changyou Zhan, Liangfang Zhang, Ronnie H. Fang, Ying Man, Weiwei Gao, Cao Xie, Jiarong Zhou, Ashley V. Kroll and Danni Ran and has published in prestigious journals such as Advanced Materials, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

Xiaoli Wei

86 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Engineered Cell‐Membrane‐Coated Nanoparticles Directly Present Tumor Antigens to Promote Anticancer Immunity

2020 297 citations Yao Jiang, Xiaoli Wei et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiaoli Wei China	34	2.3k	1.8k	1.7k	488	390	88	4.3k
Diana Dehaini United States	18	1.9k 0.8×	2.4k 1.3×	1.5k 0.9×	834 1.7×	378 1.0×	20	4.0k
Jiarong Zhou United States	27	1.9k 0.8×	2.2k 1.2×	1.0k 0.6×	1.1k 2.2×	330 0.8×	38	4.1k
Jonathan A. Copp United States	10	1.3k 0.6×	1.9k 1.0×	1.3k 0.7×	535 1.1×	268 0.7×	19	3.0k
Junjie Liu China	45	2.0k 0.9×	3.4k 1.9×	2.1k 1.2×	496 1.0×	1.5k 3.8×	138	5.9k
Hong Pan China	34	1.5k 0.7×	2.1k 1.1×	858 0.5×	1.0k 2.1×	377 1.0×	72	3.7k
Zongmin Zhao United States	33	1.7k 0.7×	1.5k 0.8×	1.2k 0.7×	732 1.5×	367 0.9×	71	4.3k
Zhenjia Wang United States	25	1.3k 0.6×	1.6k 0.9×	792 0.5×	920 1.9×	370 0.9×	40	3.3k
Michael Evangelopoulos United States	30	1.7k 0.8×	1.7k 0.9×	1.3k 0.7×	553 1.1×	357 0.9×	51	3.3k
Allan E. David United States	32	1.2k 0.5×	1.7k 1.0×	1.9k 1.1×	180 0.4×	677 1.7×	64	3.8k
Silvia Muro United States	41	1.9k 0.8×	973 0.5×	1.6k 1.0×	370 0.8×	419 1.1×	100	4.8k

Countries citing papers authored by Xiaoli Wei

Since Specialization

Citations

This map shows the geographic impact of Xiaoli Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoli Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoli Wei more than expected).

Fields of papers citing papers by Xiaoli Wei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoli Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoli Wei. The network helps show where Xiaoli Wei may publish in the future.

Co-authorship network of co-authors of Xiaoli Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoli Wei. A scholar is included among the top collaborators of Xiaoli Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoli Wei. Xiaoli Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wei, Xiaoli, Dan‐Yun Ruan, Feng Wang, et al.. (2025). First-in-human phase 1 study of an orally bioavailable vascular-disrupting agent DX1002 in patients with advanced solid tumors. Cell Reports Medicine. 6(2). 101969–101969. 1 indexed citations

Zhang, Ruyi, et al.. (2025). Tissue-specific partitioning of flavonoids and phenolic acids coordinates bioactivities in Ormosia henryi Prain. BMC Plant Biology. 25(1). 1309–1309. 1 indexed citations

Zhou, Ji‐Chao, Yuanyuan Liu, Xiaoli Wei, et al.. (2024). Glycnsisitin A: A promising bicyclic peptide against heart failure that facilitates TFRC-mediated uptake of iron in cardiomyocytes. Acta Pharmaceutica Sinica B. 14(7). 3125–3139. 5 indexed citations

Guo, Zhongyuan, Xiaoli Wei, Yao Jiang, et al.. (2024). A genetically engineered neuronal membrane-based nanotoxoid elicits protective immunity against neurotoxins. Bioactive Materials. 38. 321–330. 1 indexed citations

Wei, Xiaoli, et al.. (2023). Physicochemical properties and adsorption state of aluminum adjuvants with different processes in vaccines. Heliyon. 9(8). e18800–e18800. 5 indexed citations

Wei, Xiaoli, et al.. (2023). Effects of thinning on the understory light environment of different stands and the photosynthetic performance and growth of the reforestation species Phoebe bournei. Journal of Forestry Research. 35(1). 14 indexed citations

Gao, Ning, et al.. (2023). Mitochondrial DNA methylation is a predictor of immunotherapy response and prognosis in breast cancer: scRNA-seq and bulk-seq data insights. Frontiers in Immunology. 14. 1219652–1219652. 5 indexed citations

An, Jing, et al.. (2022). Transcriptome analysis reveals the accelerated expression of genes related to photosynthesis and chlorophyll biosynthesis contribution to shade-tolerant in Phoebe bournei. BMC Plant Biology. 22(1). 268–268. 31 indexed citations

Ding, Tianhao, Juan Guan, Mengke Wang, et al.. (2020). Natural IgM dominates in vivo performance of liposomes. Journal of Controlled Release. 319. 371–381. 39 indexed citations

10.

Zhang, Gang, Brian T. Luk, Xiaoli Wei, et al.. (2019). Selective cell death of latently HIV-infected CD4+ T cells mediated by autosis inducing nanopeptides. Cell Death and Disease. 10(6). 419–419. 38 indexed citations

11.

Wang, Hua, Rui Yang, Fengqi Liu, et al.. (2019). R2-8018 reduces the proliferation and migration of non-small cell lung cancer cells by disturbing transactivation between M3R and EGFR. Life Sciences. 234. 116742–116742. 7 indexed citations

12.

Wang, Chenhong, et al.. (2018). Polyion complexes of a cationic antimicrobial peptide as a potential systemically administered antibiotic. International Journal of Pharmaceutics. 554. 284–291. 30 indexed citations

13.

Chai, Zhilan, Xuefeng Hu, Xiaoli Wei, et al.. (2017). A facile approach to functionalizing cell membrane-coated nanoparticles with neurotoxin-derived peptide for brain-targeted drug delivery. Journal of Controlled Release. 264. 102–111. 215 indexed citations

14.

Zhan, Changyou, et al.. (2015). Toxins and derivatives in molecular pharmaceutics: Drug delivery and targeted therapy. Advanced Drug Delivery Reviews. 90. 101–118. 40 indexed citations

15.

Yu, Jinmei, Rengong Zhuo, Peng Peng, et al.. (2015). P7, a novel antagonist of corticotropin releasing factor receptor type 1 (CRFR1) screened from phage display library. Biochemical and Biophysical Research Communications. 463(3). 200–204. 1 indexed citations

16.

Wei, Xiaoli, Jie Gao, Changyou Zhan, et al.. (2015). Liposome-based glioma targeted drug delivery enabled by stable peptide ligands. Journal of Controlled Release. 218. 13–21. 120 indexed citations

17.

Wu, Qian, et al.. (2014). [Survey of Hepatitis B infection and vaccination status among drug users in Xi'an].. PubMed. 48(10). 862–6. 4 indexed citations

18.

Qiu, Fang, et al.. (2014). Increased expression of acid-sensing ion channel 3 within dorsal root ganglia in a rat model of bone cancer pain. Neuroreport. 25(12). 887–893. 16 indexed citations

19.

Yang, Yiyi, Zhiqiang Yan, Dai‐Xu Wei, et al.. (2013). Tumor-penetrating peptide functionalization enhances the anti-glioblastoma effect of doxorubicin liposomes. Nanotechnology. 24(40). 405101–405101. 53 indexed citations

20.

Yan, Zhiqiang, Fei Wang, Ziyi Wen, et al.. (2011). LyP-1-conjugated PEGylated liposomes: A carrier system for targeted therapy of lymphatic metastatic tumor. Journal of Controlled Release. 157(1). 118–125. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact